Bodner, Ruth A <br/><br/>
Pharmacological promotion of inclusion formation: a therapeutic approach for Huntington's and Parkinson's diseases.  [electronic resource] 

 -  Proceedings of the National Academy of Sciences of the United States of America  Mar 2006 
 - 4246-51 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0027-8424 
<br/><br/><label>Standard No.: </label>10.1073/pnas.0511256103  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Amino Acid Sequence<br/>Animals<br/>Base Sequence<br/>CHO Cells<br/>Cell Line<br/>Cricetinae<br/>DNA, Recombinant--genetics<br/>Genes, Reporter<br/>Green Fluorescent Proteins--genetics<br/>Humans<br/>Huntingtin Protein<br/>Huntington Disease--drug therapy<br/>In Vitro Techniques<br/>Inclusion Bodies--drug effects<br/>Nerve Tissue Proteins--chemistry<br/>Nuclear Proteins--chemistry<br/>Parkinson Disease--drug therapy<br/>Piperazines--pharmacology<br/>Proteasome Endopeptidase Complex--metabolism<br/>Protein Folding<br/>Quinolines--pharmacology<br/>Recombinant Fusion Proteins--chemistry<br/>alpha-Synuclein--toxicity